Beyond Achondroplasia: Identifying Hypochondroplasia in Pediatric Practice

Saturday, October 03, 2026

CME Satellite Symposium at the AAP, Ballroom INDIGO A

Hilton Bayfront Hotel - 1 Park Boulevard

San Diego, CA

Schedule
* Times are PST
06:30 PM	Registration and Buffet Dinner
06:40 PM	Welcome, Introductions, Supporter Acknowledgement
06:45 PM	Seeing Short Stature through a Different Lens: Recognizing HCH in Primary Care Joshua "Yoshi" Rothman, MD, MS Clinical Assistant Professor Department of Pediatrics Medical Director, Informatics Academic Pediatrics UCSD Academic General Pediatrics San Diego, CA
07:05 PM	Understanding HCH: Clinical Features, Ntural History, and Disease Burden Nadia Merchant, MD Associate Professor Department of Pediatrics Children's Medical Center of Dallas Dallas, TX
07:30 PM	Diagnostic Evaluation and the Role of FGFR3 Genetic Testing Mahim Jain, MD, PhD Statistical Geneticist Director of the Division of Orthogenetics Nemours Children’s Hospital Wilmington, DE
07:55 PM	Management and Multidisciplinary Care
08:15 PM	Closing Comments and Q&A
08:30 PM	Adjourn

Accreditation

EXCEL Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

EXCEL Continuing Education designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Royal College MOC. Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 1 of the Royal College’s MOC Program.

Educational Objectives

At the conclusion of this conference, you should be able to:

Differentiate hypochondroplasia from achondroplasia and idiopathic short stature
Identify clinical red flags suggestive of hypochondroplasia in pediatric patients
Apply appropriate diagnostic strategies, including when to pursue FGFR3 genetic testing
Evaluate patient cases to determine next best steps in diagnosis and management

Supporter

BIOMARIN PHARMACEUTICAL

Conferences